Actively Recruiting
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
Led by Anhui Provincial Hospital · Updated on 2024-09-19
70
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this study was to explore the efficacy and safety of neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy in patients with locally advanced esophageal squamous cell carcinoma
CONDITIONS
Official Title
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ages 18-75
- Radical operation for esophageal cancer
- Esophageal squamous cell carcinoma confirmed by postoperative pathology
- Preoperative imaging and postoperative pathology stage pIIB-IVA (AJCC eighth edition): T≥3 or N+
- At least 12 lymph nodes surgically removed
- Postoperative ECOG score 0-1, able to tolerate postoperative adjuvant radiotherapy and immunotherapy
- Informed consent signed by patient or family member
You will not qualify if you...
- Younger than 18 years or older than 75 years
- Did not receive radical resection of esophageal cancer, including palliative resection
- Postoperative pathology shows non-esophageal squamous cell carcinoma
- Stage pI, IIA, or IVB after preoperative imaging and postoperative pathology (AJCC eighth edition)
- Fewer than 12 lymph nodes surgically removed
- Postoperative ECOG score 2-3, unable to tolerate postoperative adjuvant radiotherapy and immunotherapy
- Patient or family member did not sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Anhui provincial hospital
Hefei, China
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here